| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 ACSL4 MDN1 RALBP1 SMC1B SLC27A4 | 3.42e-05 | 614 | 95 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 6.70e-05 | 3 | 95 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | ligase activity | 1.84e-04 | 174 | 95 | 6 | GO:0016874 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.53e-04 | 441 | 95 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B ADSS1 | 3.06e-04 | 775 | 95 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.54e-04 | 206 | 95 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | spectrin binding | 5.61e-04 | 34 | 95 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B ADSS1 | 6.21e-04 | 839 | 95 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B ADSS1 | 6.28e-04 | 840 | 95 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B ADSS1 | 6.28e-04 | 840 | 95 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ABRA DIP2B SPAST DCDC1 ANK3 DCTN2 SPTAN1 COBL RP1 SNCB PLK1 FMNL1 FKBP4 ADSS1 | 6.78e-04 | 1099 | 95 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | very long-chain fatty acid-CoA ligase activity | 9.83e-04 | 10 | 95 | 2 | GO:0031957 | |
| GeneOntologyMolecularFunction | K48-linked polyubiquitin modification-dependent protein binding | 9.83e-04 | 10 | 95 | 2 | GO:0036435 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 1.20e-03 | 11 | 95 | 2 | GO:0047676 | |
| Domain | AMP-binding | 1.49e-05 | 30 | 94 | 4 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 1.49e-05 | 30 | 94 | 4 | IPR000873 | |
| Domain | VWFA | 5.83e-05 | 82 | 94 | 5 | PS50234 | |
| Domain | VWA | 6.54e-05 | 84 | 94 | 5 | SM00327 | |
| Domain | VWF_A | 1.43e-04 | 99 | 94 | 5 | IPR002035 | |
| Domain | VWA | 1.81e-04 | 56 | 94 | 4 | PF00092 | |
| Domain | Spin-Ssty | 2.48e-04 | 5 | 94 | 2 | PF02513 | |
| Domain | DMAP_binding | 2.48e-04 | 5 | 94 | 2 | PF06464 | |
| Domain | SPIN/Ssty | 2.48e-04 | 5 | 94 | 2 | IPR003671 | |
| Domain | AMP_BINDING | 3.69e-04 | 28 | 94 | 3 | PS00455 | |
| Domain | DMAP1-bd | 3.71e-04 | 6 | 94 | 2 | IPR010506 | |
| Domain | DMAP_binding | 3.71e-04 | 6 | 94 | 2 | SM01137 | |
| Domain | - | 5.18e-04 | 7 | 94 | 2 | 3.10.20.230 | |
| Domain | DC | 6.88e-04 | 8 | 94 | 2 | PS50309 | |
| Domain | Doublecortin_dom | 6.88e-04 | 8 | 94 | 2 | IPR003533 | |
| Domain | P-loop_NTPase | SAMD9 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B ADSS1 | 1.11e-03 | 848 | 94 | 12 | IPR027417 |
| Domain | - | SAMD9 ERCC6 SPAST VWA8 CHD7 RFC1 DHX9 MDN1 GNAO1 RAB26 SMC1B | 1.30e-03 | 746 | 94 | 11 | 3.40.50.300 |
| Domain | ATPase_dyneun-rel_AAA | 2.19e-03 | 14 | 94 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.19e-03 | 14 | 94 | 2 | PF07728 | |
| Domain | Integrin_alpha_C_CS | 2.87e-03 | 16 | 94 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 3.64e-03 | 18 | 94 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 3.64e-03 | 18 | 94 | 2 | PF08441 | |
| Domain | Integrin_alpha | 3.64e-03 | 18 | 94 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 3.64e-03 | 18 | 94 | 2 | PS00242 | |
| Domain | DSRM | 4.05e-03 | 19 | 94 | 2 | SM00358 | |
| Domain | Int_alpha_beta-p | 4.05e-03 | 19 | 94 | 2 | IPR013519 | |
| Domain | Int_alpha | 4.05e-03 | 19 | 94 | 2 | SM00191 | |
| Domain | dsrm | 4.49e-03 | 20 | 94 | 2 | PF00035 | |
| Domain | FG_GAP | 5.42e-03 | 22 | 94 | 2 | PS51470 | |
| Pubmed | ANK3 VWA8 TRIP11 NKRF DHX9 ACSL4 IGF2R MDN1 SARS1 NUAK1 TSPYL5 FKBP4 SLC27A4 | 2.50e-08 | 634 | 97 | 13 | 34591612 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.67e-07 | 316 | 97 | 9 | 31665637 | |
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 11767049 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.34e-06 | 497 | 97 | 10 | 36774506 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.83e-06 | 219 | 97 | 7 | 31353912 | |
| Pubmed | 4.54e-06 | 12 | 97 | 3 | 24785407 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 ERCC6 SPTAN1 CHD7 UBXN1 RFC1 NKRF DHX9 ACSL4 MDN1 UBN1 AKAP13 PLK1 BTRC SLC27A4 | 5.08e-06 | 1353 | 97 | 15 | 29467282 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DIP2B SPAST SPTAN1 CDK14 TRIP11 FSIP2 PANK2 MDN1 IKBKE COBL AKAP13 PLK1 | 5.10e-06 | 861 | 97 | 12 | 36931259 |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 38579707 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20575108 | ||
| Pubmed | GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons. | 7.70e-06 | 2 | 97 | 2 | 33107105 | |
| Pubmed | 1.04e-05 | 176 | 97 | 6 | 28692057 | ||
| Pubmed | 1.19e-05 | 503 | 97 | 9 | 36217030 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2B VWA8 TASP1 BANF1 IGF2R MDN1 UBN1 NUAK1 DIP2C COBL AKAP13 PRRC2B CREB3 | 1.24e-05 | 1105 | 97 | 13 | 35748872 |
| Pubmed | 1.47e-05 | 187 | 97 | 6 | 26460568 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | A2M KMT2B DCTN2 SPTAN1 CHGA RFC1 NKRF PDIA4 WFIKKN1 TLE1 SURF2 PLK1 BTRC | 1.48e-05 | 1124 | 97 | 13 | 21900206 |
| Pubmed | HSPD1 TIGAR ANK3 VWA8 DCTN2 SPTAN1 DHX9 PDIA4 DNAJC17 IGF2R MDN1 SARS1 LRPAP1 AKAP13 FKBP4 | 1.56e-05 | 1487 | 97 | 15 | 33957083 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.61e-05 | 190 | 97 | 6 | 15161933 | |
| Pubmed | 1.69e-05 | 288 | 97 | 7 | 38496616 | ||
| Pubmed | 1.78e-05 | 403 | 97 | 8 | 35253629 | ||
| Pubmed | HSPD1 DIP2B RETSAT ITGAX DHX9 ACSL4 IGF2R MDN1 AKAP13 PLD1 FMNL1 SLC27A4 NCKAP1L | 2.21e-05 | 1168 | 97 | 13 | 19946888 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17236128 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12394648 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20651280 | ||
| Pubmed | Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia. | 2.31e-05 | 3 | 97 | 2 | 19423133 | |
| Pubmed | A2M VWA8 SPTAN1 TASP1 CHD7 RFC1 NKRF ACSL4 SPIN1 RALBP1 AKR1B10 CDK11B PLD1 PRRC2B | 2.69e-05 | 1371 | 97 | 14 | 36244648 | |
| Pubmed | 2.97e-05 | 565 | 97 | 9 | 20458337 | ||
| Pubmed | ANK3 SPTAN1 PPP2R3B BANF1 PDIA4 ACSL4 IGF2R SMG7 PLK1 FKBP4 BTRC PRRC2B | 3.60e-05 | 1049 | 97 | 12 | 27880917 | |
| Pubmed | ZNF536 EGLN1 CHD7 PDIA4 IGF2R TLE1 LRPAP1 AKAP13 CDK11B SLC27A4 | 3.93e-05 | 733 | 97 | 10 | 34672954 | |
| Pubmed | HSPD1 ZNF536 KMT2B SPTAN1 CHD7 RFC1 BANF1 NKRF PDIA4 SMG7 UBN1 TLE1 FKBP4 PRRC2B | 4.23e-05 | 1429 | 97 | 14 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.35e-05 | 457 | 97 | 8 | 32344865 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 25361009 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 16885022 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 16885021 | ||
| Pubmed | PLK1 and β-TrCP-dependent ubiquitination and degradation of Rap1GAP controls cell proliferation. | 4.60e-05 | 4 | 97 | 2 | 25329897 | |
| Pubmed | Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease. | 4.60e-05 | 4 | 97 | 2 | 20637261 | |
| Pubmed | Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1. | 4.60e-05 | 4 | 97 | 2 | 24501426 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 12972258 | ||
| Pubmed | Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA. | 4.60e-05 | 4 | 97 | 2 | 34156981 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 7589890 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 DIP2B VWA8 ZNF618 SPTAN1 CHD7 NKRF DHX9 SPIN1 TSPYL5 CDK11B SPIN3 | 4.85e-05 | 1082 | 97 | 12 | 38697112 |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 5.21e-05 | 143 | 97 | 5 | 30397336 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 5.22e-05 | 344 | 97 | 7 | 30333137 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.70e-05 | 475 | 97 | 8 | 31040226 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | UBXN1 CDK14 DHX9 PDIA4 PANK2 SARS1 NUAK1 IKBKE TLE1 AKAP13 CDK11B FKBP4 SLC27A4 | 5.84e-05 | 1284 | 97 | 13 | 17353931 |
| Pubmed | 6.69e-05 | 486 | 97 | 8 | 20936779 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HSPD1 DIP2B VWA8 EGLN1 TRIP11 NKRF DHX9 PDIA4 ACSL4 MDN1 SARS1 PLK1 FKBP4 PRRC2B | 6.91e-05 | 1496 | 97 | 14 | 32877691 |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 16650578 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 7514554 | ||
| Pubmed | Phosphorylation of synucleins by members of the Polo-like kinase family. | 7.66e-05 | 5 | 97 | 2 | 19889641 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 9688542 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 8118099 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 25453754 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 32963106 | ||
| Pubmed | Plk1- and beta-TrCP-dependent degradation of Bora controls mitotic progression. | 7.66e-05 | 5 | 97 | 2 | 18378770 | |
| Pubmed | Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora. | 7.66e-05 | 5 | 97 | 2 | 18521620 | |
| Pubmed | 8.38e-05 | 371 | 97 | 7 | 15747579 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 8.42e-05 | 647 | 97 | 9 | 26618866 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 ANK3 DCTN2 SPTAN1 RFC1 BANF1 DHX9 PDIA4 MDN1 SARS1 SPIN1 FKBP4 | 8.59e-05 | 1149 | 97 | 12 | 35446349 |
| Pubmed | 9.03e-05 | 653 | 97 | 9 | 22586326 | ||
| Pubmed | Localization of Cacna1s to ON bipolar dendritic tips requires mGluR6-related cascade elements. | 1.15e-04 | 6 | 97 | 2 | 24519419 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 23027877 | ||
| Pubmed | HSF1 as a mitotic regulator: phosphorylation of HSF1 by Plk1 is essential for mitotic progression. | 1.15e-04 | 6 | 97 | 2 | 18794143 | |
| Pubmed | Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. | 1.15e-04 | 6 | 97 | 2 | 24176642 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 19822658 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.15e-04 | 6 | 97 | 2 | 23728480 | |
| Pubmed | A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1. | 1.15e-04 | 6 | 97 | 2 | 29061846 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 25503564 | ||
| Pubmed | UBXN1 RFC1 BANF1 NKRF DHX9 DNAJC17 MDN1 UBN1 TLE1 CDK11B FKBP4 | 1.24e-04 | 1014 | 97 | 11 | 32416067 | |
| Pubmed | 1.25e-04 | 172 | 97 | 5 | 23184937 | ||
| Pubmed | 1.29e-04 | 35 | 97 | 3 | 23969696 | ||
| Pubmed | 1.30e-04 | 847 | 97 | 10 | 35850772 | ||
| Pubmed | 1.31e-04 | 174 | 97 | 5 | 32149426 | ||
| Pubmed | 1.55e-04 | 549 | 97 | 8 | 38280479 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 1.60e-04 | 7 | 97 | 2 | 7495297 | |
| Pubmed | A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. | 1.65e-04 | 38 | 97 | 3 | 18247557 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 1.73e-04 | 558 | 97 | 8 | 35063084 | |
| Pubmed | HSPD1 VWA8 DCTN2 SPTAN1 RFC1 BANF1 NKRF MDN1 UBN1 COBL BTRC PRRC2B SLC27A4 | 1.83e-04 | 1440 | 97 | 13 | 30833792 | |
| Pubmed | 1.89e-04 | 101 | 97 | 4 | 18519826 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 15469984 | ||
| Pubmed | HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. | 2.13e-04 | 8 | 97 | 2 | 15875659 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 8725284 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 19633172 | ||
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 12684064 | ||
| Pubmed | Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. | 2.13e-04 | 8 | 97 | 2 | 16075307 | |
| Pubmed | 2.13e-04 | 8 | 97 | 2 | 23413029 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.24e-04 | 580 | 97 | 8 | 35676659 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.30e-04 | 582 | 97 | 8 | 20467437 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | UBXN1 CDK14 RETSAT NUAK1 IKBKE RALBP1 ANKRD36 CDK11B PLK1 BTRC | 2.31e-04 | 910 | 97 | 10 | 36736316 |
| Pubmed | HSPD1 SPTAN1 UBXN1 RFC1 RETSAT DHX9 PDIA4 IGF2R LRPAP1 AKAP13 FKBP4 PRRC2B | 2.64e-04 | 1297 | 97 | 12 | 33545068 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.69e-04 | 203 | 97 | 5 | 22083510 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 30554948 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 22688677 | ||
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 2.74e-04 | 9 | 97 | 2 | 28533443 | |
| Pubmed | Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. | 2.74e-04 | 9 | 97 | 2 | 15004035 | |
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 26680696 | ||
| Pubmed | 2.74e-04 | 9 | 97 | 2 | 9882526 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 2.74e-04 | 9 | 97 | 2 | 7544347 | |
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 2.74e-04 | 9 | 97 | 2 | 16951254 | |
| Pubmed | Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway. | 2.74e-04 | 9 | 97 | 2 | 18570250 | |
| Interaction | RIPK4 interactions | HSPD1 SPAST ANK3 VWA8 PDIA4 MDN1 SARS1 SMG7 FKBP4 BTRC SLC27A4 | 8.10e-06 | 446 | 95 | 11 | int:RIPK4 |
| Cytoband | 18p11.3 | 2.40e-04 | 11 | 97 | 2 | 18p11.3 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.23e-04 | 5 | 64 | 2 | 1089 | |
| GeneFamily | Doublecortin superfamily | 5.45e-04 | 10 | 64 | 2 | 1369 | |
| GeneFamily | Zinc fingers CXXC-type | 7.96e-04 | 12 | 64 | 2 | 136 | |
| GeneFamily | AAA ATPases | 8.73e-04 | 53 | 64 | 3 | 413 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.82e-03 | 18 | 64 | 2 | 1160 | |
| GeneFamily | Cyclin dependent kinases | 3.80e-03 | 26 | 64 | 2 | 496 | |
| GeneFamily | Acyl-CoA synthetase family | 3.80e-03 | 26 | 64 | 2 | 40 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M SP100 SAMD9 ANK3 SPTAN1 EGLN1 ITGA2 RETSAT CFB CRP ACSL4 OLFML2A IGF2R TLE1 AKR1B10 AKAP13 PLD1 | 4.10e-06 | 1276 | 97 | 17 | M39173 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HSPD1 CHD7 UBXN1 TRIP11 SARS1 UBN1 RRN3 SPIN1 SURF2 DIP2C TSPYL5 GNAO1 FKBP4 PRRC2B | 9.99e-06 | 946 | 97 | 14 | M39169 |
| Coexpression | GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP | 1.22e-05 | 137 | 97 | 6 | M415 | |
| Coexpression | KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP | HSPD1 GABRD DCTN2 SPTAN1 CDK14 SARS1 NUAK1 COBL LRPAP1 SNCB PRRC2B CREB3 | 2.27e-05 | 755 | 97 | 12 | M2105 |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.58e-06 | 178 | 97 | 6 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-06 | 189 | 97 | 6 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.00e-06 | 192 | 97 | 6 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.24e-06 | 194 | 97 | 6 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 4.63e-06 | 197 | 97 | 6 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.05e-06 | 200 | 97 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 157 | 97 | 5 | 542944030cd9b3f3559e64f9f6598694d74003c0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 157 | 97 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-05 | 171 | 97 | 5 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 3.74e-05 | 172 | 97 | 5 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 175 | 97 | 5 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 175 | 97 | 5 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 175 | 97 | 5 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-05 | 175 | 97 | 5 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.76e-05 | 181 | 97 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 183 | 97 | 5 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.15e-05 | 184 | 97 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 5.42e-05 | 186 | 97 | 5 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.56e-05 | 187 | 97 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 187 | 97 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-05 | 189 | 97 | 5 | 0daa8efac08dca9525d2b8d421952068cab4eb50 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-05 | 189 | 97 | 5 | b6bb4327b4560d07d2b728abcc5f144f428948a5 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.85e-05 | 189 | 97 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.99e-05 | 190 | 97 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 6.30e-05 | 192 | 97 | 5 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 192 | 97 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.46e-05 | 193 | 97 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 194 | 97 | 5 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | CV-Severe-6|Severe / Virus stimulation, Condition and Cluster | 6.61e-05 | 194 | 97 | 5 | d33be6ed1de907aeea0c2dce09796556b8efdd4e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-05 | 194 | 97 | 5 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.11e-05 | 197 | 97 | 5 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | d73585a5587941483db8d9ddc2d68f7d852bbbc8 | |
| ToppCell | 390C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-05 | 198 | 97 | 5 | 623e5ada1a54cd42c32a1519b84dbe782384ee0c | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 7.28e-05 | 198 | 97 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 199 | 97 | 5 | 722b9ebf7e47c361a7f192689a8d46947ec62b45 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 199 | 97 | 5 | 7816ad127b16208b1046da53f4a295b4a747b4cc | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 199 | 97 | 5 | 9d24223b571fba202455c5bd49bd79530abf09c0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-05 | 199 | 97 | 5 | 06cf08b4a60670f583895a79488524b7b386b2f0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.64e-05 | 200 | 97 | 5 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-05 | 200 | 97 | 5 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 7.64e-05 | 200 | 97 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | COVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class | 7.64e-05 | 200 | 97 | 5 | b586b0f1127293c2f8529be16b24229359041da2 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class | 7.64e-05 | 200 | 97 | 5 | f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 113 | 97 | 4 | 357bc20edc5bc14eab8262d52260ed1686e9dc54 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 113 | 97 | 4 | 91e73e3b93be242fef0f14eddd8085a1f1c730ef | |
| Computational | Genes in the cancer module 412. | 5.26e-05 | 13 | 63 | 3 | MODULE_412 | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.81e-06 | 196 | 96 | 8 | 5863_UP | |
| Drug | tripropargylamine | 1.76e-05 | 2 | 96 | 2 | CID000023351 | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 1.78e-05 | 193 | 96 | 7 | 2567_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.90e-05 | 195 | 96 | 7 | 4581_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 4728_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.96e-05 | 196 | 96 | 7 | 6591_DN | |
| Drug | 5194442; Down 200; 20uM; PC3; HT_HG-U133A | 2.03e-05 | 197 | 96 | 7 | 6594_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 1818_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.10e-05 | 198 | 96 | 7 | 3550_UP | |
| Disease | Liver carcinoma | A2M GABRD KMT2B CDK14 CRP ACSL4 OLFML2A IGF2R AKR1B10 GNAO1 PLK1 | 6.61e-07 | 507 | 94 | 11 | C2239176 |
| Disease | Infection | 2.09e-04 | 7 | 94 | 2 | C3714514 | |
| Disease | Endotoxemia | 2.78e-04 | 8 | 94 | 2 | C0376618 | |
| Disease | juvenile rheumatoid arthritis (is_marker_for) | 2.78e-04 | 8 | 94 | 2 | DOID:676 (is_marker_for) | |
| Disease | symmetrical dimethylarginine measurement | 3.56e-04 | 9 | 94 | 2 | EFO_0006523 | |
| Disease | end stage renal disease (is_marker_for) | 4.30e-04 | 46 | 94 | 3 | DOID:783 (is_marker_for) | |
| Disease | neuroimaging measurement | HSPD1 DIP2B SAMD9 KMT2B DCDC1 ANK3 CHD7 CFB NUAK1 GNAO1 PLD1 | 5.94e-04 | 1069 | 94 | 11 | EFO_0004346 |
| Disease | uric acid measurement | 7.46e-04 | 610 | 94 | 8 | EFO_0004761 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 8.91e-04 | 14 | 94 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | eosinophil percentage of granulocytes | 9.30e-04 | 234 | 94 | 5 | EFO_0007996 | |
| Disease | quinate measurement | 1.03e-03 | 15 | 94 | 2 | EFO_0021167 | |
| Disease | breast carcinoma (is_marker_for) | 1.24e-03 | 66 | 94 | 3 | DOID:3459 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.32e-03 | 17 | 94 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Age-related macular degeneration | 1.49e-03 | 18 | 94 | 2 | cv:C0242383 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.51e-03 | 154 | 94 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | metabolite measurement, diet measurement | 1.53e-03 | 71 | 94 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.66e-03 | 19 | 94 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Omenn Syndrome | 1.66e-03 | 19 | 94 | 2 | C2700553 | |
| Disease | Pheochromocytoma | 1.66e-03 | 19 | 94 | 2 | C0031511 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.74e-03 | 160 | 94 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Lewy Body Disease | 2.23e-03 | 22 | 94 | 2 | C0752347 | |
| Disease | prostate carcinoma (is_marker_for) | 2.43e-03 | 23 | 94 | 2 | DOID:10286 (is_marker_for) | |
| Disease | frailty measurement | 2.43e-03 | 23 | 94 | 2 | EFO_0009885 | |
| Disease | Dystonia | 2.65e-03 | 86 | 94 | 3 | C0013421 | |
| Disease | chronic hepatitis B virus infection | 2.65e-03 | 24 | 94 | 2 | EFO_0004239 | |
| Disease | eosinophil percentage of leukocytes | 2.65e-03 | 746 | 94 | 8 | EFO_0007991 | |
| Disease | cortical thickness | 2.88e-03 | 1113 | 94 | 10 | EFO_0004840 | |
| Disease | macular degeneration (is_marker_for) | 3.10e-03 | 26 | 94 | 2 | DOID:4448 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGDIPEGYSVSREKK | 76 | A0A5B6 | |
| AVSKFGKKDSLGTRE | 86 | O60488 | |
| GGSGKTRTKDKYRVV | 146 | P47902 | |
| NKRIVSGAYDGKIKV | 516 | Q9Y297 | |
| GAVDSKVASYEKKVR | 2186 | Q12802 | |
| GKVKEAVKVAIDAGY | 26 | O60218 | |
| DSVLNIARGKKYGEK | 1071 | A6QL64 | |
| IARGKKYGEKTKRVS | 1076 | A6QL64 | |
| EGTYGVVYRAKDKKT | 446 | P21127 | |
| KADSYEKLEKLGEGS | 131 | O94921 | |
| RSIAKEGFEKISKGA | 121 | P10809 | |
| KYGLDGKKDARQVTS | 121 | P30533 | |
| DRIGKTKRTGYESGE | 71 | Q13561 | |
| SKKEIEDLLRKGAYG | 1456 | Q9P2D1 | |
| GSYKVVVQKKSGGRT | 201 | P01023 | |
| YRVSGIKSKVDELKA | 231 | Q15311 | |
| VVKREDGEKLAKEYG | 186 | Q9ULW5 | |
| TRGRKVQKEGKISYA | 361 | Q9Y5P8 | |
| VITDGKKEGDSLDYK | 256 | P20702 | |
| TRKEVYIKNGDKKGS | 641 | P00751 | |
| KKERGTFDYRIDGKG | 861 | P0DP91 | |
| IRVKAAEGTSLEGYK | 726 | M0R2J8 | |
| YTALRKESGTKLVDG | 941 | Q9NU22 | |
| ASVYKARNKKSGELV | 21 | Q14164 | |
| EKEVLGSDSEIGYKK | 5596 | Q5CZC0 | |
| LSEGDITQKGYEKKR | 31 | Q9P265 | |
| GTVYLVSDKKAKRGE | 41 | Q8NG66 | |
| SLKGYGKRVADIKES | 311 | P55160 | |
| YRSVGVETGETKKEG | 391 | O14764 | |
| SVLTDKREKFYDGKG | 2611 | Q9UMN6 | |
| KKEEGRVYLFTIKEG | 521 | P17301 | |
| GDSTKVDKLVRDIYG | 441 | Q9BZ23 | |
| VLGALEAKTGVEKRY | 21 | Q96HR9 | |
| NRIAKGTFKVDGKEY | 81 | Q96C23 | |
| IAEVSTKDVKVYGKG | 201 | P31327 | |
| YEKLATGESIAVKKR | 671 | Q96SD1 | |
| GVLSGEFTKEREKAK | 331 | Q13698 | |
| KVKDKVYGCADGERT | 646 | O75128 | |
| RKSLKKGYTVGAEAS | 136 | P02741 | |
| LSEGDITQKGYEKKR | 26 | Q9Y2E4 | |
| SKIYKDVSENGVGKV | 2516 | Q12955 | |
| KEDESKGGYSKDVLL | 181 | Q9NVM6 | |
| RARAKVKYLTGEKGV | 396 | Q9GZT9 | |
| KLKSYVDTGGVSRKV | 86 | O95466 | |
| RVSVRKELKGGKAYA | 81 | Q5T8I3 | |
| TIVKERGTVYFKEGK | 271 | Q02790 | |
| GKKLEERGFDKAYVV | 31 | O75531 | |
| ESRRKKKVYVGGLES | 166 | O43889 | |
| VEAYSGLTKKKEGET | 256 | Q08211 | |
| ARGKGKDISKYGSVQ | 226 | Q68BL7 | |
| GFVKRAIEKLYGKAD | 1626 | P56715 | |
| GATDGKKRYDLSALV | 476 | P11717 | |
| AELKGKRGSDYETFK | 476 | Q6NUM9 | |
| VDGKVDNGKTKDLYR | 331 | Q9NYV6 | |
| ELYKVIGKGSEKSDD | 246 | P49591 | |
| EKTKEGVLYVGSKTR | 31 | Q16143 | |
| KYGVVEGKALSELRA | 91 | Q9NQ88 | |
| GEVKVGVSYKLNGKR | 371 | Q8N142 | |
| EAVGVKKTVKYEAAG | 491 | O15226 | |
| VGKKETETKYGIRID | 286 | Q13393 | |
| ERYGGKVTGNVSKKT | 431 | P35251 | |
| KASKEEDFYRGGKVS | 676 | Q5K651 | |
| KTDYVKRKGFITVDG | 2801 | P25391 | |
| LGIEYGDKERKADAK | 91 | P09471 | |
| RDYSKGITVTKNDGK | 571 | Q92540 | |
| KKETGKDRVQSGSYL | 201 | Q8NDV1 | |
| LGKGTYGKVKRATER | 61 | O60285 | |
| KILKKGQAVDYEGSR | 141 | P13667 | |
| ETTVYRGLVQKRGKK | 216 | Q15527 | |
| LTSKYVGEGEKLVRA | 411 | Q9UBP0 | |
| YGRPKEGTKTAERAK | 286 | Q8N0Z2 | |
| GYKEIRKGESRSEAL | 261 | P10645 | |
| DKYIVTGSGDKKATV | 751 | Q04724 | |
| IKSYVLGVKGADIRD | 576 | Q5T7W0 | |
| DETRKKVKAYGKEGV | 331 | Q70EL2 | |
| GEKSVKYKERGKAFT | 261 | Q8TB69 | |
| ESGKKEYSLDTRGKF | 136 | Q9GZS3 | |
| TGTYKFQKTELRKEG | 591 | Q6P1M0 | |
| SGELIGEYEEKKRKL | 161 | Q8NDV3 | |
| KQVEYAKEDGSKRTG | 216 | Q9Y657 | |
| GKQVEYAKDDGSKRT | 211 | Q5JUX0 | |
| KEKKLLVGSEDYGRD | 1781 | Q13813 | |
| EVKGTLYKERFKQGT | 611 | P23497 | |
| SVGDAKTRYKLKVEG | 2091 | P24821 | |
| KYKGKSVDAIRSSVI | 26 | Q5JSZ5 | |
| TEKGRTVKAVYGVSK | 606 | Q9H0V1 | |
| RIEKVIYTGKEGKSS | 871 | O43151 | |
| DKAERAKKYGGSVGS | 171 | Q04323 | |
| KEKREYVLVGADGSK | 561 | O15090 | |
| EVKKRLDSEYKEGGQ | 116 | Q96HH6 | |
| AGSYVRAASEKRVKK | 516 | Q96NZ8 | |
| LKGENEKIVETYRGK | 1461 | Q15643 | |
| VEALARKFEEKYGGK | 101 | Q9NPG3 | |
| GTDTSFYRGKKKRGT | 1396 | A3KMH1 | |
| AEKRKRTTGAKYGDV | 66 | Q6NT04 | |
| ETKQSYKEKRGGFVL | 31 | Q9H6P5 | |
| KGDIAEGYSVSREKK | 76 | A0A075B6N1 | |
| YLLSEGARVEKGKEK | 381 | Q86VY4 | |
| GLATKVEYDGERKKT | 196 | P53350 | |
| KNKYGGEKIDVTVSV | 1421 | P54296 |